Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-pyrrolidinecarboxamide
2. Prolinamide
3. Prolinamide, (l)-isomer
1. 7531-52-4
2. Prolinamide
3. H-pro-nh2
4. (s)-pyrrolidine-2-carboxamide
5. (s)-prolinamide
6. (2s)-pyrrolidine-2-carboxamide
7. L-proline Amide
8. L-prolineamide
9. (s)-2-pyrrolidinecarboxamide
10. 58274-20-7
11. Proline Amide
12. (s)-proline Amide
13. 2-pyrrolidinecarboxamide,(s)-
14. L-(-)-prolinamide
15. Vd6pqk9dhg
16. (2s)-2-pyrrolidinecarboxamide
17. Chebi:21374
18. Mfcd00005253
19. (s)-pyrrolidine-2-carboxylic Acid Amide
20. 2-pyrrolidinecarboxamide, (2s)-
21. Unii-vd6pqk9dhg
22. (2s)-2-carbamoylpyrrolidine
23. Proline Imide
24. (2s)pyrrolidine-2-carboxamide
25. L-proline Amid
26. (2s)-prolinamide
27. Lpd
28. Einecs 231-397-0
29. Pronh2
30. L-(-) Prolinamide
31. H-pronh2
32. L-pronh2
33. L-prolinamide, 98%
34. Prolinamide, L-
35. 2-pyrrolidinecarboxamide #
36. Ec 231-397-0
37. H-l-pro-nh2
38. Schembl240170
39. (s)-prrolidine-2-carboxamide
40. (s)-2-pyrrolidine Carboxamide
41. Chembl1222059
42. 2-pyrrolidinecarboxamide, (s)-
43. Dtxsid00226268
44. Zinc391898
45. Act05030
46. Albb-014823
47. Cs-d1209
48. Akos005174571
49. Akos015854494
50. Ncgc00159402-02
51. Ac-24602
52. Ac-25877
53. Bp-10428
54. Hy-20582
55. Ts-01579
56. Db-029980
57. Am20100732
58. P1382
59. A26952
60. C19781
61. S)-pyrrolidine-2-carboxylic Acid Amide
62. (2s)-pyrrolidine-2-carboxamide (l-prolinamide)
63. 429p276
64. A839595
65. J-524162
66. Q-102892
67. Q27103084
68. F1905-7145
69. (s)-pyrrolidine-2-carboxylic Acid Amide;(s)-prolinamide; L-proline Amide;l-(-)-prolinamide
| Molecular Weight | 114.15 g/mol |
|---|---|
| Molecular Formula | C5H10N2O |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 114.079312947 g/mol |
| Monoisotopic Mass | 114.079312947 g/mol |
| Topological Polar Surface Area | 55.1 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 103 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A L Prolinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L Prolinamide, including repackagers and relabelers. The FDA regulates L Prolinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L Prolinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L Prolinamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L Prolinamide supplier is an individual or a company that provides L Prolinamide active pharmaceutical ingredient (API) or L Prolinamide finished formulations upon request. The L Prolinamide suppliers may include L Prolinamide API manufacturers, exporters, distributors and traders.
click here to find a list of L Prolinamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L Prolinamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L Prolinamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L Prolinamide GMP manufacturer or L Prolinamide GMP API supplier for your needs.
A L Prolinamide CoA (Certificate of Analysis) is a formal document that attests to L Prolinamide's compliance with L Prolinamide specifications and serves as a tool for batch-level quality control.
L Prolinamide CoA mostly includes findings from lab analyses of a specific batch. For each L Prolinamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L Prolinamide may be tested according to a variety of international standards, such as European Pharmacopoeia (L Prolinamide EP), L Prolinamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L Prolinamide USP).
LOOKING FOR A SUPPLIER?
